|

Quemliclustat Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: AB680

Pipeline

Phase 2: 2

Top Sponsors

  • Nataliya Uboha1
  • Catherine Spina1

Indications

  • Cancer2
  • Biliary Tract Carcinoma1
  • Bile Duct Cancer1
  • Oligometastatic Prostate Cancer1
  • Cholangiocarcinoma1

Indianapolis, Indiana1 trial

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Phase 2

New York, New York1 trial

Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer

Columbia University Irving Medical Center / NewYork-Presbyterian Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.